[A casuistic contribution to therapy with gestagen in metastasizing corpus carcinoma (author's transl)].
Casuistic contribution of a sucessfully with Gestagen treated stage IV corpus carcinoma which previously had been operated and undergone radiotherapy. Ten years after the primary treatment the patient presented herself asymptomatic and clinically free of a tumor. The possible mechanism of the effect of the Gestagen-therapy is discussed as well as the indication for the administration of Gestagen in a corpus carcinoma.
D000368:Aged; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009640:Norethindrone / Q000627:therapeutic use*; D013997:Time Factors; D014228:Triaziquone / Q000627:therapeutic use; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D014625:Vaginal Neoplasms / Q000188:drug therapy
D003520:Cyclophosphamide; D014228:Triaziquone; D009640:Norethindrone
Kasuistischer Beitrag zur Gestagen-Therapie beim metastasierenden Korpuskarzinom.